BR9609631A - 1,6-disubstituted isochromans for the treatment of migraine headaches - Google Patents
1,6-disubstituted isochromans for the treatment of migraine headachesInfo
- Publication number
- BR9609631A BR9609631A BR9609631A BR9609631A BR9609631A BR 9609631 A BR9609631 A BR 9609631A BR 9609631 A BR9609631 A BR 9609631A BR 9609631 A BR9609631 A BR 9609631A BR 9609631 A BR9609631 A BR 9609631A
- Authority
- BR
- Brazil
- Prior art keywords
- isochromans
- disubstituted
- treatment
- migraine headaches
- headaches
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74195P | 1995-06-30 | 1995-06-30 | |
| US1123496P | 1996-02-06 | 1996-02-06 | |
| PCT/US1996/008681 WO1997002259A1 (en) | 1995-06-30 | 1996-06-07 | 1,6-disubstituted isochromans for treatment of migraine headaches |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9609631A true BR9609631A (en) | 1999-03-02 |
Family
ID=26668092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9609631A BR9609631A (en) | 1995-06-30 | 1996-06-07 | 1,6-disubstituted isochromans for the treatment of migraine headaches |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0836599A1 (en) |
| JP (1) | JPH11509532A (en) |
| AU (1) | AU6252296A (en) |
| BR (1) | BR9609631A (en) |
| CA (1) | CA2225282A1 (en) |
| CZ (1) | CZ418597A3 (en) |
| FI (1) | FI974640A0 (en) |
| MX (1) | MX9710260A (en) |
| NO (1) | NO976112L (en) |
| PL (1) | PL324319A1 (en) |
| SK (1) | SK164297A3 (en) |
| WO (1) | WO1997002259A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2370270A (en) * | 2000-12-20 | 2002-06-26 | Lilly Co Eli | Pharmaceutical compounds |
| GB0130339D0 (en) * | 2001-12-19 | 2002-02-06 | Lilly Co Eli | Isochroman compounds |
| US7335660B2 (en) | 2001-12-19 | 2008-02-26 | Eli Lilly And Company | Isochroman compounds for treatment of CNS disorders |
| US7110576B2 (en) | 2002-12-30 | 2006-09-19 | Pitney Bowes Inc. | System and method for authenticating a mailpiece sender |
| ATE458727T1 (en) | 2004-05-05 | 2010-03-15 | Hoffmann La Roche | ARYLSULFONYLBENZODIOXANES SUITABLE FOR MODULATION OF THE 5-HT6 RECEPTOR, THE 5-HT2A RECEPTOR OR BOTH RECEPTORS |
| PL1831152T3 (en) | 2004-12-21 | 2009-03-31 | Hoffmann La Roche | Tetralin and indane derivatives and uses thereof as 5-ht antagonists |
| SI1831159T1 (en) | 2004-12-21 | 2010-04-30 | Hoffmann La Roche | Tetralin and indane derivatives and uses thereof |
| CN101119989B (en) | 2004-12-21 | 2010-06-09 | 弗·哈夫曼-拉罗切有限公司 | Chroman derivatives and uses thereof in treating CNS disease |
| CA2591793A1 (en) | 2004-12-21 | 2006-06-29 | F. Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof |
| ATE396183T1 (en) | 2004-12-21 | 2008-06-15 | Hoffmann La Roche | CHROMEAND DERIVATIVES AND THEIR USE AS LIGANDS OF THE 5-HT RECEPTOR |
| WO2007051735A1 (en) | 2005-11-03 | 2007-05-10 | F. Hoffmann-La Roche Ag | Arylsulfonylchromans as 5-ht6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors |
| AU2007263084A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof |
| AU2007263075A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Arylsulfonamidyl tetralin derivatives and uses thereof |
| AU2007263076A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Arylsulfonyl naphthalene derivatives and uses thereof |
| JP2010229128A (en) * | 2009-03-05 | 2010-10-14 | Sumitomo Chemical Co Ltd | Halogen-substituted terephthalic acid diamide compound, method for producing the same, and method for producing halogen-substituted benzene dimethanol by using the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552004A (en) * | 1976-05-26 | 1979-09-05 | Takeda Chemical Industries Ltd | Isochroman derivatives |
| ATE182590T1 (en) * | 1993-12-28 | 1999-08-15 | Upjohn Co | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR AND CENTRAL NERVOUS SYSTEM DISORDERS |
-
1996
- 1996-06-07 PL PL96324319A patent/PL324319A1/en unknown
- 1996-06-07 MX MX9710260A patent/MX9710260A/en unknown
- 1996-06-07 CA CA002225282A patent/CA2225282A1/en not_active Abandoned
- 1996-06-07 AU AU62522/96A patent/AU6252296A/en not_active Abandoned
- 1996-06-07 SK SK1642-97A patent/SK164297A3/en unknown
- 1996-06-07 WO PCT/US1996/008681 patent/WO1997002259A1/en not_active Application Discontinuation
- 1996-06-07 EP EP96921264A patent/EP0836599A1/en not_active Withdrawn
- 1996-06-07 JP JP9505135A patent/JPH11509532A/en active Pending
- 1996-06-07 CZ CZ974185A patent/CZ418597A3/en unknown
- 1996-06-07 BR BR9609631A patent/BR9609631A/en not_active Application Discontinuation
-
1997
- 1997-12-29 NO NO976112A patent/NO976112L/en unknown
- 1997-12-30 FI FI974640A patent/FI974640A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI974640A (en) | 1997-12-30 |
| CZ418597A3 (en) | 1998-06-17 |
| NO976112L (en) | 1998-03-02 |
| NO976112D0 (en) | 1997-12-29 |
| PL324319A1 (en) | 1998-05-25 |
| FI974640A0 (en) | 1997-12-30 |
| WO1997002259A1 (en) | 1997-01-23 |
| MX9710260A (en) | 1998-03-29 |
| CA2225282A1 (en) | 1997-01-23 |
| SK164297A3 (en) | 1998-09-09 |
| JPH11509532A (en) | 1999-08-24 |
| EP0836599A1 (en) | 1998-04-22 |
| AU6252296A (en) | 1997-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA97631B (en) | Migraine treatment. | |
| NO981800L (en) | Process for the preparation of 1,1,1,3,3-pentafluoropentane | |
| BR9609631A (en) | 1,6-disubstituted isochromans for the treatment of migraine headaches | |
| DE69515997T2 (en) | TRANSCODER | |
| AU2825295A (en) | Method for the treatment, prevention or minimization of hair loss | |
| IT1292552B1 (en) | DEVICE FOR THE APPLICATION OF COATINGS. | |
| BR9605759A (en) | Continuous process for the preparation of 4-mino-2,2,6,6-tetramethylpiperidine | |
| IT1303677B1 (en) | DEVICE FOR THE HEAT TREATMENT OF PIECES. | |
| PT928183E (en) | USES OF 1-HYDROXYL-2-PYRIDONENE FOR THE TREATMENT OF SEBORROIC DERMATITIS | |
| FI972058A0 (en) | For the purposes of this Regulation, this Regulation shall apply | |
| DK0815092T3 (en) | Process for the preparation of 1,2-benzisothiazolin-3-ones | |
| NO985535D0 (en) | Process for the preparation of 1,3-alkanediols | |
| ZA965548B (en) | 1,6-disubstituted isochromans for treatment of migraine headaches | |
| HUP9802226A3 (en) | 1,6-disubstituted isochromans for treatment of migraine headaches | |
| ID16434A (en) | COMPOUNDS OF 1,4-DIHYDROPIRIDINS | |
| FI940088A0 (en) | Regulation / Regulation For the purposes of this Regulation, the provisions of this Regulation shall apply | |
| IT1295973B1 (en) | PROCEDURE FOR LIGHTING OBJECTS. | |
| DK0737068T3 (en) | 2,3-diaryl-1-benzopyrans for the treatment of dermatitis | |
| DK0783491T3 (en) | Process for the preparation of 3,3,5-trichloro-glutarimide | |
| ES1029021Y (en) | LONG FOR THE FORMATION OF SHELVES. | |
| ITTV940061A0 (en) | "PAGE, PARTICULARLY FOR THE PRACTICE OF FENCING". | |
| ITRM940468A0 (en) | "USE OF ESTERURETHANES FOR LS TANNING". | |
| FI941868A0 (en) | For the purposes of this Regulation, the provisions of this Regulation shall apply. | |
| FI973824A0 (en) | For the purposes of this Regulation, the provisions of this Regulation shall apply | |
| ITTO940097V0 (en) | SHREDDING DEVICE, PARTICULARLY FOR THE SHREDDING OF PAPER-LAGINE. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law |